000 | 01507 a2200445 4500 | ||
---|---|---|---|
005 | 20250511122740.0 | ||
264 | 0 | _c19800530 | |
008 | 198005s 0 0 eng d | ||
022 | _a0073-5655 | ||
024 | 7 |
_a10.1007/BF02618254 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCholon, J J | |
245 | 0 | 0 |
_aInhibition of cellular transition from G1-resting to G1-prereplicative phase by aminonucleoside of puromycin. _h[electronic resource] |
260 |
_bIn vitro _cSep 1979 |
||
300 |
_a736-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCell Transformation, Neoplastic |
650 | 0 | 4 | _aCell Transformation, Viral |
650 | 0 | 4 | _aCulture Media |
650 | 0 | 4 |
_aDNA _xbiosynthesis |
650 | 0 | 4 |
_aDNA, Neoplasm _xbiosynthesis |
650 | 0 | 4 | _aFetal Blood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterphase _xdrug effects |
650 | 0 | 4 |
_aLung _xembryology |
650 | 0 | 4 |
_aPuromycin _xanalogs & derivatives |
650 | 0 | 4 |
_aPuromycin Aminonucleoside _xpharmacology |
650 | 0 | 4 |
_aRNA _xbiosynthesis |
650 | 0 | 4 |
_aRNA, Neoplasm _xbiosynthesis |
650 | 0 | 4 |
_aRNA, Ribosomal _xbiosynthesis |
650 | 0 | 4 |
_aSimian virus 40 _xgrowth & development |
700 | 1 | _aKnopf, R G | |
700 | 1 | _aPine, R M | |
773 | 0 |
_tIn vitro _gvol. 15 _gno. 9 _gp. 736-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02618254 _zAvailable from publisher's website |
999 |
_c256877 _d256877 |